MedTrace Logo

FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease

NCT05504811 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2025-12-24

No results posted yet for this study

Summary

This study will investigate the efficacy of a newly developed exercise device (FitMi AD) for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease. FitMi AD uses embedded sensors that can track and record the patient's direction and degree of movement while performing exercises described on a computer.

Conditions

  • Cognitive Dysfunction
  • Dementia, Mild

Interventions

OTHER

Conventional exercise program

Exercise following printed sheets or booklet

DEVICE

FitMi AD

Exercise using the motion sensing devices and a tablet computer

Sponsors & Collaborators

  • Rancho Research Institute, Inc.

    collaborator OTHER

  • Flint Rehabilitation Devices, LLC

    lead INDUSTRY

Principal Investigators

  • Freddi Segal-Gidan, PA, PhD · Rancho Research Institute, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-08
Primary Completion
2025-03-12
Completion
2025-03-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05504811 on ClinicalTrials.gov